Express Scripts claims to be the No. 1 company in the mail order prescription business. In this video, Fool analyst Jim Mueller explains the Express Scripts business and the three things investors need to watch. Mail order prescriptions are attracting the attention of big pharma and generics alike, and how well Express Scripts penetrates these markets is critical to its future success.
The key things Express Scripts investors need to be paying attention to.
About the Author
Advisor for Motley Fool Options, Future of Entertainment, and Energy Insider, Jim learned how businesses are run while putting his Ph.D. in biochemistry to use at a small biotech company. Jim started investing over two decades ago, initially making the same mistakes most people do. He changed careers to work at the Fool, where he's improved his investing process while developing an appreciation for the importance of investor psychology and taking the long-term view. He received the CFA charter in 2015.
